FluoroPharma Medical, Inc.
FPMI
$0.0001
$0.000.00%
OTC PK
| 12/31/2016 | 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | |
|---|---|---|---|---|---|
| Net Income | 89.96% | 266.16% | 48.59% | -173.92% | -1,249.18% |
| Total Depreciation and Amortization | -1.80% | 3.74% | -6.78% | -14.06% | -13.28% |
| Total Amortization of Deferred Charges | -31.54% | -50.12% | 620.83% | 736.59% | 1,049.01% |
| Total Other Non-Cash Items | -1,846.32% | 20.82% | -141.66% | 318.59% | 102.42% |
| Change in Net Operating Assets | 1,143.38% | -35.17% | 219.47% | -20.61% | -104.79% |
| Cash from Operations | 87.99% | 42.90% | 140.92% | -0.92% | -110.53% |
| Capital Expenditure | 100.00% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -- | -- | -- | -- |
| Total Debt Issued | -- | -94.54% | -47.50% | -25.00% | -100.00% |
| Total Debt Repaid | -33.33% | -- | -- | -- | -200.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -103.86% | 99.48% | 97.16% | -210.53% | 235.54% |
| Cash from Financing | 414.40% | -93.18% | -39.93% | -23.39% | -105.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.72% | -130.24% | 936.22% | -50.24% | -625.10% |